Revolutionizing anti-tumor therapy: unleashing the potential of B cell-derived exosomes

Jingwen Xiong(Southwest Medical University), Gang Tian(Affiliated Hospital of Southwest Medical University), Songyun Zhao(Wenzhou Medical University), Hao Chi(University of Hawaiʻi at Mānoa), Fang Yang(Anhui Provincial Hospital), Jing Zhang(Xijing Hospital), Lisa Jia Tran(Ludwig-Maximilians-Universität München), Guanhu Yang(Ohio University), Zhijia Xia(Ludwig-Maximilians-Universität München)
Frontiers in Immunology
June 5, 2023
10.3389/fimmu.2023.1188760
Cited by 77

Related Papers

Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
|New England Journal of Medicine|2021|742
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target
|Cell Research|2021|198
Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC
|Frontiers in Immunology|2022|178
T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing
|Frontiers in Immunology|2023|153
A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration
|Frontiers in Genetics|2022|124